RUNX2 and hyperphosphatemia: In response to hyperphosphatemia, inflammation, and oxidative stress, VSMCs lose their contractile phenotype and adopt osteoblast-like features, driven by transcription factors such as Runx2, BMP2, and Msx2 [24].